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Abstract 13 
 14 
 15 
This study prospectively assessed the outcome of 134 cemented titanium stems and 16 
serum ion levels. The stems were smooth and collarless with circular cross-sections. 17 
At endpoint, only one stem revision was performed for aseptic loosening, and two were 18 
planned due to subsidence superior to 5 millimetres. Non-progressive radiolucencies in zones 19 
1 and 7 were observed in 16 hips at the cement-interface, without osteolysis. Median serum 20 
titanium concentrations were below the detection limit (30 nmol/l) except in patients with 21 
failed stems.  22 
The overall stem survival rate was 97.7% at a mean follow-up of 9 years, which is 23 
comparable to other series of cemented stems. The protective layer of titanium oxide coating 24 
the stem and a thick cement mantle may help resist aseptic loosening.  25 
 26 
 27 
 28 
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 30 
Introduction 31 
 32 
Titanium and its alloys are commonly used for orthopaedic implants such as screws, 33 
plates, and spinal implants. This success is explained by the mechanical and biological 34 
properties of these materials such as resistance to fatigue, low elasticity modulus to reduce 35 
stress shielding, and bio inertness in a physiological environment [1,2]. Despite these 36 
properties, the use of polished cemented titanium stems is still debated [3-5]. Titanium stems 37 
are thought to be highly sensitive to corrosion and micromotion leading to early aseptic 38 
loosening [4,5,6].  39 
Like other metallic orthopaedic implants, titanium stems can release metal debris and ions 40 
from their coated surface that may also contribute to titanium stem failure [7-11]. Several 41 
previous studies investigated ion and particle release into the biological fluid from joint 42 
replacement, but to the best of our knowledge no series concerning cemented titanium stems 43 
are available [12-15]. 44 
In this prospective study, we hypothesized that satisfactory results could be reached with 45 
cemented smooth titanium stems that are oval in section. In addition, the titanium ions 46 
released into the serum from the stems was measured up to the last time-point, in both 47 
unilateral and bilateral hip replacements, to monitor the behaviour of the stems. 48 
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1 Materials and methods 49 
 50 
Demographic data: From January 1997 to December 2000, we prospectively 51 
followed a consecutive series of 109 patients who underwent primary total hip replacements 52 
performed at our institution (134 joint replacements/ 25 bilateral). All patients provided 53 
informed consent for the long duration of this prospective clinical and biological study. They 54 
received complete information, including the goals and procedures for blood sampling.  55 
The inclusion criteria were strict; patients with orthopaedic titanium implants other than their 56 
hip stem, professional or dental exposure to titanium, previous hip conservative surgical 57 
procedures, or renal disease were excluded. Additionally, all patients enrolled were under 60 58 
years of age at the time of surgery. In our practice, this represented less than 20% of all 59 
primary total hip arthroplasty performed during the study period. 60 
 61 
The average follow up was 9 years, with follow up ranging from 7 to 11 years. The age at the 62 
time of arthroplasty ranged from 30 to 60 years (mean age: 54 years). Fifty-three females and 63 
56 males were included. Sixty eight right hips were treated, and 66 left hips. Etiologies were 64 
essentially symptomatic stage of osteonecrosis or primary arthritis. Patients were evaluated 65 
preoperatively and followed-up with clinical and radiological examinations at regular 66 
intervals. Hip function results were rated according to the Harris Hip Score grading system in 67 
the preoperative period and latest follow up [16].  68 
 69 
Prostheses: The cemented femoral stem was collarless, oval in cross section, and 70 
straight (Alizé
®
 Fournitures Hospitalières, Quimper, France). The implant was made of 71 
titanium alloy (TiA16V4) with a polished surface coated with titanium oxide (TiO2) obtained 72 
by anodization [17,18]. The thickness of the titanium oxide layer was 1/10000 micron. Six 73 
different sized stems were available. 74 
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This modular stem was combined with a 28 millimeter (mm) Metasul® femoral head 75 
(Centerpulse-Zimmer, Warsaw, Indiana, U.S.) using a 12 – 14, 5°43 taper.  76 
Tapers were inspected individually before micro threading, using an electro pneumatic 77 
system (HIGH PRESSURE ELECTRONIC PNEUMO TRANSDUCER 150015, Solex Metrologie, La 78 
Boisse, France) for the taper angle (precision, 1 minute), the diameter at the base, and the 79 
diameter at the summit (precision, 1 micron). This inspection was counter-checked by a unit 80 
control on a tridimensional machine with 1-micron precision. The micro threading was 81 
inspected using a projected side view with a 20x enlargement for the pace, profile, and 82 
dimension of the threading (Pexit 14 VS Profile Profector, Pixit Dorsey Gage, Cambridge, 83 
UK). Compatibility between cones and heads were controlled and guaranteed by the 84 
manufacturers. All of the sockets were “sandwich” cemented Metasul® cups (Weber cups, 85 
Centerpulse-Zimmer, Warsaw, Indiana, U.S.). Palacos Genta® cement (Scherring Plough, 86 
Brussels, Belgium) was used to cement both components in all cases. 87 
 88 
Surgical technique: All procedures were performed following the standard procedure 89 
at our institution via an antero-lateral approach on a Judet orthopaedic table [19]. In order to 90 
obtain a complete and thick cement mantle, the canal was over-reamed by 2 mm. Then the 91 
femoral canal was washed, brushed, and distally occluded by a resorbable femoral plug 92 
(Synplug®, Zimmer, Warsaw, Indiana, U.S). The cement was inserted retrogradedly using a 93 
gun.  94 
  Radiological evaluation and clinical assessment: Anteroposterior (AP) and lateral 95 
radiographs of each hip were available before and immediately after surgery, 6 weeks after 96 
discharge from the hospital, and at 3 months, 6 months, 1 year, and then yearly thereafter.  97 
We defined radiographic loosening of the cup as the presence of radiolucent lines measuring 98 
at least two millimeters according to DeLee-Charnley zones, axial cup migration of > 5 mm, 99 
or > 5° of change in cup inclination on the AP radiographs of the pelvis [20]. 100 
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Parameters investigated on the femoral side included presence and progression of radiolucent 101 
lines according to Gruen et al, calcar resorption or atrophy, subsidence, periprosthetic 102 
osteolysis, and cortical hypertrophy [21]. Loosening of the stem was defined as a migration 103 
exceeding 3 mm or a continuous radiolucent line greater than 2 mm. Heterotopic 104 
ossifications, if present, were graded according to Brooker et al. [22]. 105 
 106 
 107 
Titanium serum level determination: In order to determine titanium release from the 108 
femoral stem, dosages were determined in two patient groups: those with unilateral 109 
replacements and those with bilateral replacements. Blood samples were taken just before 110 
implantation and at 3 months, 6 months, 1 year, and then yearly thereafter until the last end 111 
point was reached. 112 
To avoid metallic contamination, blood samples were drawn using a sampling kit specifically 113 
dedicated to trace element determination: a needle for S-Monovette
®
 (ref. 85.1162.400) and 114 
7.5 mL S-Monovette
®
 Lithium Heparin for Trace Metal analysis (ref. 01.1604.400) from 115 
Sarstedt (Marnay, France). Two Monovettes were sampled and numbered in sampling order. 116 
After centrifugation, aliquots of plasma were placed in metal-free plastic tubes (2 117 
tubes/sample) and frozen at – 20°C. All metal measurements were performed on two samples 118 
in order to control for any contamination.  119 
Titanium was measured in blood plasma diluted by Inductively Coupled Optical Emission 120 
Spectrometry (ICP-OES) on a JY24 spectrometer® (Jobin Yvon, Longjumeau, France). The 121 
detection limit (DL) was 30 nmol/L of plasma. Concentrations under the DL were set at half 122 
the DL value (15 nmol/L) to allow for statistical calculation by convention. 123 
Meanwhile, chromium and cobalt were also determined in the serum from the same samples. 124 
Cobalt and chromium were determined by Electrothermal Atomic Absorption Spectrometry 125 
on a simultaneous SIMAA 5100 spectrometer® UNTIL 2004, and then 6100 (Perkin Elmer, 126 
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Courtabœuf, France). The detection limits were 3 nmol/L for cobalt and 1 nmol/L for 127 
cromium. Seronorm Levels I and II (Sero, distributed by Ingen, Rungis, France) were 128 
analyzed in each analytical run as internal quality controls. The serum titanium level was 129 
expressed in nmol/L (1 nmol/L = 47.9 ng/L=0.0479 µg/L =0.0479 ppb). 130 
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Statistical analysis 131 
 132 
Survival analyses were calculated according to the Kaplan-Meier method. Loosened stems 133 
(revised or not) were considered as end points. For each time-point, the median as well as the 134 
twenty-fifth and seventy-fifth percentiles of serum titanium concentrations were calculated in 135 
the unilateral and the bilateral replacement groups. Continuous data were tested for normal 136 
distribution using the Kolmogorov-Smirnov test. Normally distributed data were analysed 137 
with t-tests. 138 
In order to test for any difference between small stems and larger ones regarding subsidences 139 
or radiolucencies, we selected two subgroups of stems within the unilateral hip replacement 140 
group. The first subgroup was composed of stems with a size of 1 to 3. In the second 141 
subgroup, the sizes of the stems ranged from 4 to 6. A non-parametric Wilcoxon test was 142 
performed to detect any difference in these 2 subgroups. Statistical significance was set at p 143 
<0.05. 144 
All statistical analyses were carried out with PRISM 3 (GraphPad Software, Inc,San Diego, 145 
U.S.).146 
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Results 147 
 148 
Survival rate (Fig 1): Overall stem survival (loosened, revised or not) was 97.7% at a 149 
mean follow-up of 9 years (95% CI, 95.4%–99.5%). 150 
 151 
Complications: Two recurrent dislocations required revisions due to impingement 152 
between the titanium femoral neck and the edge of the chromium-cobalt insert of the cup, 1 153 
month and 6 months, respectively, after the implantation. At the time of revision, the 154 
components were not loosened; black staining of the joint space was observed due to titanium 155 
release from femoral neck notches. In both cases, the patient’s serum titanium levels were 156 
high due to the release of titanium from the femoral neck lesions. All of the components were 157 
revised with the same polished cemented stem and a cemented polyethylene cup.  158 
Eight revisions were performed for loosened Metasul® cemented cups with radiolucencies 159 
superior to 2 millimeters and osteolysis.  160 
In the first 3 cases, hips were revised using new metal-on-metal or polyethylene cups with 161 
respect to the femur. 162 
Considering the high cobalt-chromium serum levels and the local conditions in 2 revision 163 
cases, the bearing surfaces were converted to alumina-on-alumina using a new cementless 164 
stem. In last three cases, the hips were revised using alumina-on-alumina with sleeved 165 
femoral heads (Ceramtec, Plochingen, Germany) as the taper and the stem fixation was intact.  166 
One case of progressive subsidence due to poor cement technique required a unipolar femoral 167 
revision using a cementless stem, 5 years after implantation. 168 
One prosthesis was revised due to persistent and unexplained pain. At the time of the 169 
revision, we found no abnormalities apart from a massive and macroscopic metallosis of the 170 
joint. The cobalt serum level was increased more than 20-fold compared with the detection 171 
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limit. The implants were changed, and new metal-on-metal bearing surfaces were again 172 
implanted, but did not resolve the symptoms. 173 
 174 
Clinical results: The mean Harris Hip Score improved significantly (p<0.05) from 39 175 
(range 15-68) preoperatively to 91 (range 83-97) at the ultimate follow-up.  176 
 177 
Radiological results: We observed 4 cases with osteolysis and 16 cases with 178 
evolutive radiolucencies at the cement-bone interface on the acetabular side. 179 
Three stem subsidences due to poor cement technique were identified on the early 180 
postoperative radiographs. Two were inferior to 10 mm and slowly evolutive with time 181 
requiring potential revision in the future (Fig 2). The third was of more concern (subsidence 182 
superior to 10 mm) and was revised, as mentioned previously. It was associated with 183 
osteolysis in zone 6 of Delee and Charnley [20]. 184 
Non-progressive femoral radiolucent lines were present in zone 1 at the cement-prosthesis 185 
interface in 10 hips, and had spread into zone 7 in six more hips. We did not observe femoral 186 
hypertrophic reaction around the distal stem or calcar resorption. 187 
No statistically significant difference (p > 0.05) was observed between small and large 188 
titanium stems regarding subsidences (p=0.74) and radiolucency frequencies (p=0.96). 189 
Periarticular ossification, according to the method of Broocker et al. [22], was observed in 190 
30% of the hips. Eight percent were type III and IV. 191 
 192 
Serum titanium concentration: In both the unilateral and bilateral replacement groups, the 193 
median titanium concentration was constant and within range, and always below the 194 
detection limit of 15 nmol/l (Tables 1 and 2). 195 
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Failed stems, as shown in Table 3, caused the highest titanium serum levels at their end-point 196 
in the series, and titanium levels were much higher than the detection limit ranging from 196 197 
to 1274 nmol/l. 198 
Titanium serum levels remained below the detection limit in cases with loosened cups.  199 
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Discussion  200 
 201 
Use of cemented titanium alloy stems remains extremely controversial and has caused 202 
some surgeons to renounce them [3-5]. Some series showed a large rate of early aseptic 203 
loosening, usually when the stem was rough and cemented [4-6,23-25]. Jergesen reported an 204 
11.5% aseptic loosening rate in a series of 118 total hip replacements at a mean follow-up of 205 
66 months [6]. In the Scholl E series, the revision rate was 88% at a mean of 6.6 years due to 206 
loosened stems, and 30% of cases showed a significant osteolysis of the proximal femur [26].  207 
Two factors are suggested that explain the early stem failure for the cemented titanium 208 
solutions. Firstly, the high elasticity of titanium and the excessive stresses in the mantle of the 209 
cement could lead to micromotion and debonding of the stem [4]. Micro-movements at the 210 
cement-stem interface may be responsible for cement mantle breakage and titanium-debris 211 
generation inducing necrosis and osteolysis [23]. The failure risk could be higher for smaller 212 
stems due to their greater elasticity, and in males who are physically active [26], while larger 213 
diameter titanium stems may be more successful [6]. In our series, we did not observe this 214 
relationship.  215 
The second factor in early stem failure for the cemented titanium implants could be corrosion 216 
affecting the cemented, titanium alloy, stem surface. The implant could be deeply damaged 217 
by micromotion at the cement-stem interface leading to a progressive abrasion, which later 218 
induces a surface corrosion. Retrieval studies on loosened titanium alloy cemented stems 219 
report severe corrosion with associated typical crevices [5,27]. Scholl found such abrasions in 220 
corroded areas in all stem revisions with radiographic osteolysis at the same location [26]. 221 
Tissues were stained black with granuloma, including titanium wear particles. These findings 222 
suggest that corrosion could initiate an inflammatory foreign-body reaction that is responsible 223 
for the osteolysis of the adjacent bone, and aseptic loosening as seen with polyethylene wear 224 
particles. 225 
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The results of this prospective series are not in accordance with these observations. 226 
The overall survival rate of the stems was 97.7% at a mean of 9 years, which makes the 227 
failure rate consistent with the survival rate at 10 years of other cemented stems as reported in 228 
the Swedish Hip registry |28]. In the past, satisfactory results have been reported in the 229 
literature with cemented titanium stems. Known as the “French paradox”, the stems were 230 
rectangular in cross section, filling the medullary canal of the femur as much as possible with 231 
the largest implant associated with a thin cement mantle [29]. Survivorship at ten years 232 
ranged from 97% to 99% in these series [30,18].  233 
The present study demonstrated that good results could be achieved with a different 234 
design and a different concept. In this cohort, the alloyed femoral stems were smooth, 235 
anodized, collarless, oval in section proximally, and circular for the distal 2/3 to reduce stress 236 
contact areas around the implants. Collarless implants have been associated with an increase 237 
in the frequency and width of radiolucent areas in zones 2 and 7 [31]. Nevertheless, we 238 
did not find such radiographic results and the rate of radiolucent lines was low in our study 239 
(14/119) at a mean follow-up of 9 years. Moreover, Meding et al. performed a prospective 240 
randomized study of collared versus collarless femoral prosthesis and reported that there was 241 
no difference in stem subsidence or functional scores [32]. Irrespective of their design or 242 
surface coating, all stems have been shown to move inside of their cement mantle in the first 243 
years after implantation [33]. Obviously, a polished surface limits the abrasion due to 244 
micromotion and ipso facto reduces production of active biological debris. On the contrary, it 245 
is established that the roughness of the stem directly influences the amount of debris 246 
produced and the rate of femoral loosening [23,34,35]. Better results have been obtained after 247 
implantation of titanium alloy stems with a polished surface compared with a rough surface 248 
with regard to the aseptic loosening rate [36]. Resistance to abrasion and corrosion of 249 
titanium implants depends on a thin and highly protective surface of oxide film [37]. The 250 
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protective, passive, titanium oxide film (TiO2) is obtained by anodization during the 251 
manufacturing process. This titanium oxide surface protects against exposure to air or other 252 
oxidizing elements. If scratches occur, this passive layer is supposed to heal and restore itself.  253 
In our series, we experienced 3 femoral subsidences that could be clearly explained by a poor 254 
cementing technique. The cementing technique did not follow the “French paradox” 255 
guidelines; our cement mantle had to be complete and superior to 2 millimiters thickness 256 
using a pressurized cementing technique. Studies focused on stress at the interfaces 257 
demonstrated minimal micromotion of the stem when the cement mantle was 3 to 4 258 
millimeter thick around either a titanium or a more rigid, cobalt-chromium implant [38,39]. 259 
Moreover, in these studies, high micromovement occurred when the cement was thinner than 260 
2 mm and there was no difference in micromotion or debonding between a titanium and a 261 
cobalt-chromium stem [38,39]. A finite-element analysis study identified factors 262 
influencing cement strains of the femoral component [40]. The authors of this study 263 
found that mantle thickness had the greatest effect on cement strains and suggested that a 264 
cement mantle thickness of 2.5 to 5.0 mm was optimal. 265 
 266 
In addition to the clinical assessment, we measured the serum titanium levels at each 267 
patient follow-up. The only source of titanium particles and ions in this study was the femoral 268 
stem. The aim was to monitor the behaviour of the implant as previously performed with 269 
chromium or cobalt [8,41]. Regarding titanium, several previous reports have shown 270 
significantly increased levels in case of failure in arthroplasty [13,42,43]. Buly reported a 271 
series of failed cemented all-titanium alloy femoral stems with high titanium levels in either 272 
dry tissues or synovial fluid [13]. Leopold and von Schroeder reported a failed patellar 273 
component in total knee arthroplasty, with elevated serum titanium at least 20 times higher 274 
than normal values [43,44].  275 
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Although a few studies have analysed titanium release from femoral stems previously, 276 
it is difficult to compare their results with ours because of differences in the type of stems 277 
(design, coating, etc), mean follow-up, and units [12-15]. In the present study, medians were 278 
constant in range up to a mean follow-up of 9 years in both unilateral and bilateral hip 279 
replacement groups, and were always under the detection limit. The low serum 280 
concentrations observed are reassuring with regard to some concerns about potential titanium 281 
toxicity [44]. Although titanium is considered safe except for its potential osteolytic activity, 282 
it circulates throughout the body and particles have been found in hair, lungs, brain, urine, 283 
and serum [44,45].  284 
The highest titanium serum concentrations were found in cases of mechanical complications 285 
such as stem fixation (subsidences) or neck impingement. These findings are in accordance 286 
with previous studies that monitored metal release. They could also emphasize the ability of 287 
polished and titanium oxide coated surfaces to resist against corrosion and micromotion. 288 
Another potential source of titanium particle release could be the junction between the 289 
cobalt-chromium femoral head and the softer femoral taper due to fretting and corrosion. In 290 
all of our revision cases, we carefully studied the femoral taper. In the 2 revisions with an 291 
exchange of the femoral stem, both the head and taper were under the specifications and we 292 
did not observe significant lesions in the contact areas. Our interpretation of higher serum 293 
titanium levels in a few patients is the unusual fretting and corrosion of the stem against the 294 
cement mantle. In the revision cases without femoral stem exchange, an inspection of the 295 
taper did not show significant alteration of the implant, allowing us to use sleeved revision 296 
femoral heads according to the recommendations. 297 
 298 
In conclusion, this series shows that satisfactory results can be achieved using 299 
cemented, smooth, and oval in section titanium alloy stems. In addition, these results are 300 
consistent with series using other cemented implants [28]. A thick cement mantle combined 301 
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with a polished, anodized surface may play a major role in minimizing the debris source and 302 
the stress at the interfaces. 303 
The high rate of acetabular loosening in this series of cemented cups questions the potential 304 
role of titanium debris. We could not find an argument for this hypothesis. We did not 305 
observe relationships between acetabular loosening and high titanium serum levels; head-306 
neck modularity did not seem responsible. Moreover, all the tapers were intact at the time of 307 
the revision. In addition, titanium serum levels found in this study showed satisfactory 308 
monitoring of the stems.  309 
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Figures 430 
 431 
Fig 1: Survivorship of loosened stems as the end point 432 
 433 
Fig 2: After 10 years of follow-up, typical evolution of the stem could be seen in this series 434 
showing controlled subsidence  435 
 436 
Table 1 : Serum titanium levels in the unilateral hip replacement group 437 
 438 
Table 2 : Serum titanium levels in the bilateral hip replacement group 439 
 440 
Table 3 : Serum titanium levels in the group with failed stems 441 
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